chr2-96254832-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_017849.4(TMEM127):c.409+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_017849.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM127 | NM_017849.4 | c.409+1G>C | splice_donor_variant, intron_variant | ENST00000258439.8 | NP_060319.1 | |||
TMEM127 | NM_001193304.3 | c.409+1G>C | splice_donor_variant, intron_variant | NP_001180233.1 | ||||
TMEM127 | NM_001407282.1 | c.157+1G>C | splice_donor_variant, intron_variant | NP_001394211.1 | ||||
TMEM127 | NM_001407283.1 | c.157+1G>C | splice_donor_variant, intron_variant | NP_001394212.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM127 | ENST00000258439.8 | c.409+1G>C | splice_donor_variant, intron_variant | 1 | NM_017849.4 | ENSP00000258439.3 | ||||
TMEM127 | ENST00000432959.1 | c.409+1G>C | splice_donor_variant, intron_variant | 1 | ENSP00000416660.1 | |||||
TMEM127 | ENST00000435268.1 | c.157+1G>C | splice_donor_variant, intron_variant | 3 | ENSP00000411810.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary pheochromocytoma-paraganglioma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | This sequence change affects a donor splice site in intron 3 of the TMEM127 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TMEM127-related conditions. ClinVar contains an entry for this variant (Variation ID: 1065957). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the TMEM127 protein in which other variant(s) (p.Tyr178Leufs*48) have been determined to be pathogenic (PMID: 28384794, 28855235; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.